Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05082_nanopub.RA5KDajz3rtq8gDEusKqAgzj-XAdWwgVm2JVDgID-8Swg#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05082 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05082 label "ARX201 [drugbank:DB05082]" assertion.
- drugbank:DB05082 seeAlso DB05082 assertion.
- drugbank:DB05082 description "ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrxâs patented ReCODE⢠technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). ARX201 has improved pharmacological properties, which should allow less frequent administration than the daily dosing regimen of currently available growth hormones." assertion.
- drugbank:DB05082 identifier "drugbank:DB05082" assertion.
- drugbank:DB05082 title "ARX201" assertion.
- drugbank:DB05082 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05082 drugbank_vocabulary:drugbank-id "DB05082" assertion.
- drugbank:DB05082 bio2rdf_vocabulary:x-identifiers.org DB05082 assertion.
- drugbank:DB05082 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05082" assertion.
- drugbank:DB05082 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05082 bio2rdf_vocabulary:identifier "DB05082" assertion.